1. Home
  2. VERV vs CARE Comparison

VERV vs CARE Comparison

Compare VERV & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • CARE
  • Stock Information
  • Founded
  • VERV 2018
  • CARE 1974
  • Country
  • VERV United States
  • CARE United States
  • Employees
  • VERV N/A
  • CARE N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • CARE Major Banks
  • Sector
  • VERV Health Care
  • CARE Finance
  • Exchange
  • VERV Nasdaq
  • CARE Nasdaq
  • Market Cap
  • VERV 475.0M
  • CARE 400.8M
  • IPO Year
  • VERV 2021
  • CARE N/A
  • Fundamental
  • Price
  • VERV $6.14
  • CARE $17.36
  • Analyst Decision
  • VERV Strong Buy
  • CARE Buy
  • Analyst Count
  • VERV 4
  • CARE 2
  • Target Price
  • VERV $25.75
  • CARE $21.50
  • AVG Volume (30 Days)
  • VERV 1.5M
  • CARE 74.4K
  • Earning Date
  • VERV 02-25-2025
  • CARE 01-27-2025
  • Dividend Yield
  • VERV N/A
  • CARE N/A
  • EPS Growth
  • VERV N/A
  • CARE N/A
  • EPS
  • VERV N/A
  • CARE 0.62
  • Revenue
  • VERV $24,396,000.00
  • CARE $128,505,000.00
  • Revenue This Year
  • VERV $97.47
  • CARE N/A
  • Revenue Next Year
  • VERV N/A
  • CARE $19.45
  • P/E Ratio
  • VERV N/A
  • CARE $27.94
  • Revenue Growth
  • VERV 219.91
  • CARE N/A
  • 52 Week Low
  • VERV $4.31
  • CARE $10.95
  • 52 Week High
  • VERV $19.34
  • CARE $20.40
  • Technical
  • Relative Strength Index (RSI)
  • VERV 53.75
  • CARE 46.76
  • Support Level
  • VERV $5.32
  • CARE $16.00
  • Resistance Level
  • VERV $6.87
  • CARE $17.63
  • Average True Range (ATR)
  • VERV 0.52
  • CARE 0.46
  • MACD
  • VERV -0.00
  • CARE 0.06
  • Stochastic Oscillator
  • VERV 56.74
  • CARE 69.74

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. The Bank offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: